AIM
AVNS

Advantage Investment Management’s Avanos Medical AVNS Stock Holding History

Advantage Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$5K – 952
2018
Q1 		$5K Sell
100
-25
-20% -$1.19K ﹤0.01% 795
2017
Q4 		$6K Hold
125
– – ﹤0.01% 779
2017
Q3 		$6K Hold
125
– – ﹤0.01% 780
2017
Q2 		$5K Hold
125
– – ﹤0.01% 824
2017
Q1 		$5K Hold
125
– – ﹤0.01% 798
2016
Q4 		$5K Hold
125
– – ﹤0.01% 738
2016
Q3 		$4K Sell
125
-12
-9% -$420 ﹤0.01% 753
2016
Q2 		$4K Hold
137
– – ﹤0.01% 721
2016
Q1 		$4K Hold
137
– – ﹤0.01% 695
2015
Q4 		$5K Hold
137
– – ﹤0.01% 677
2015
Q3 		$4K Buy
137
+25
+22% +$872 ﹤0.01% 675
2015
Q2 		$5K Buy
112
+100
+833% +$4.49K ﹤0.01% 687
2015
Q1 		$1K Sell
12
-49
-80% -$2.27K ﹤0.01% 814
2014
Q4 		$3K Buy
+61
New +$2.4K ﹤0.01% 658

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Advantage Investment Management's AVNS Position: Q2 2018 in Review

Advantage Investment Management sold out of Avanos Medical (AVNS) in Q2 2018, closing a stake of 100 shares — an estimated $5K sold.

Advantage Investment Management first reported a position in AVNS in Q4 2014 and held it in 14 quarters. The position peaked at $6K in Q4 2017. 321 funds tracked by Wall St. Rank hold AVNS as of Q2 2018.

  • Advantage Investment Management reported no remaining Avanos Medical position as of Q2 2018 after selling out during the quarter.
  • Advantage Investment Management sold 100 Avanos Medical shares in Q2 2018, an estimated $5K.
  • Advantage Investment Management first reported a position in Avanos Medical in Q4 2014 and held it in 14 quarters.
  • Advantage Investment Management's Avanos Medical position peaked at $6K in Q4 2017.
  • 321 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2018.

Based on Advantage Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.